Progenics Pharmaceuticals (PGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 42,049 | 137,686 | 90,642 | 138,909 | 74,103 |
| Receivables | 15,976 | 3,803 | 3,972 | 4,864 | 3,543 |
| Other current assets | 5,707 | 2,640 | 2,256 | 4,328 | 5,639 |
| TOTAL | $63,732 | $144,129 | $96,870 | $148,101 | $83,285 |
| Non-Current Assets | |||||
| PPE Net | 11,688 | 3,944 | 4,122 | 4,760 | 2,407 |
| Intangibles | 24,670 | 19,740 | 43,443 | 43,655 | 43,867 |
| Other Non-Current Assets | 19,380 | 1,684 | 1,522 | 2,470 | 1,692 |
| TOTAL | $55,738 | $25,368 | $49,087 | $50,885 | $47,966 |
| Total Assets | $119,470 | $169,497 | $145,957 | $198,986 | $131,251 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,117 | 5,419 | 2,445 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,249 | 444 | 3,359 | 567 | 332 |
| Accrued Expenses | 13,103 | 10,533 | 9,555 | 15,790 | 9,212 |
| Other current liabilities | N/A | 7,050 | N/A | N/A | 185 |
| TOTAL | $22,068 | $23,446 | $15,359 | $16,357 | $9,729 |
| Non-Current Liabilities | |||||
| Long Term Debt | 31,910 | 39,180 | 47,242 | 49,453 | N/A |
| Other Non-Current Liabilities | 18,905 | 5,768 | 18,328 | 15,477 | 19,669 |
| TOTAL | $50,849 | $44,976 | $67,145 | $77,867 | $30,861 |
| Total Liabilities | $72,917 | $68,422 | $82,504 | $94,224 | $40,590 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 86,597 | 84,543 | 72,662 | 70,190 | 69,946 |
| Common Shares | 113 | 110 | 93 | 92 | 91 |
| Retained earnings | -677,760 | -609,208 | -541,586 | -490,573 | -501,379 |
| Other shareholders' equity | 111 | 154 | -1,883 | 174 | 438 |
| TOTAL | $46,553 | $101,075 | $63,453 | $104,762 | $90,661 |
| Total Liabilities And Equity | $119,470 | $169,497 | $145,957 | $198,986 | $131,251 |